Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience.
- DOI
- 10.1016/j.jbo.2026.100766
- Published
- 2026 Jun
- Container
- Journal of bone oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jbo.2026.100766,
title = {Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience.},
author = {Mahdal M and Apostolopoulos V and Múdrý P and Neradil J and Kubíček M and Zoufalý D and Adámková D and Tomáš T},
year = {2026},
journal = {Journal of bone oncology},
doi = {10.1016/j.jbo.2026.100766},
url = {https://doi.org/10.1016/j.jbo.2026.100766}
}RIS
TY - JOUR TI - Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience. AU - Mahdal M AU - Apostolopoulos V AU - Múdrý P AU - Neradil J AU - Kubíček M AU - Zoufalý D AU - Adámková D AU - Tomáš T PY - 2026 JO - Journal of bone oncology DO - 10.1016/j.jbo.2026.100766 UR - https://doi.org/10.1016/j.jbo.2026.100766 ER -
APA
M, M., V, A., P, M., J, N., M, K., D, Z., D, A., & T, T. (2026). Dual-target neoadjuvant therapy with denosumab and sunitinib for giant cell tumor of bone: a sarcoma center experience.. Journal of bone oncology. https://doi.org/10.1016/j.jbo.2026.100766
Source records
- pubmed · retrieved 2026-09-25T15:36:28.894Z